Benzinga | May 10, 2021 05:02PM EDT

AVEO Pharmaceuticals Q1 EPS $(0.81) Misses $(0.55) Estimate, Sales $1.92M Beat $1.01M Estimate

AVEO Pharmaceuticals (NASDAQ:AVEO) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.55) by 47.27 percent. This is a 55.77 percent decrease over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $1.92 million which beat the analyst consensus estimate of $1.01 million by 90.10 percent. This is a 144.90 percent increase over sales of $784.00 thousand the same period last year.